Zoran Kovačević

3.8k total citations · 1 hit paper
31 papers, 3.0k citations indexed

About

Zoran Kovačević is a scholar working on Surgery, Nephrology and Rheumatology. According to data from OpenAlex, Zoran Kovačević has authored 31 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Nephrology and 5 papers in Rheumatology. Recurrent topics in Zoran Kovačević's work include Renal Diseases and Glomerulopathies (5 papers), Systemic Lupus Erythematosus Research (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Zoran Kovačević is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Systemic Lupus Erythematosus Research (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Zoran Kovačević collaborates with scholars based in Serbia, Indonesia and United States. Zoran Kovačević's co-authors include Robert A. Figlin, Timothy E. O’Toole, Jeffrey A. Sosman, Stephanie Lustgarten, Vladimir Lesovoy, Robert J. Motzer, Elżbieta Starosławska, Piotr Tomczak, David McDermott and Ingo G.H. Schmidt‐Wolf and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and FEBS Letters.

In The Last Decade

Zoran Kovačević

30 papers receiving 2.9k citations

Hit Papers

Temsirolimus, Interferon Alfa, or Both for Advanced Renal... 2007 2026 2013 2019 2007 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
    2007 2.8k citations Gary R. Hudes, Michael A. Carducci et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zoran Kovačević Serbia 7 2.1k 2.0k 1.1k 723 246 31 3.0k
David McDermott United States 3 2.3k 1.1× 2.2k 1.1× 1.3k 1.1× 807 1.1× 301 1.2× 3 3.2k
Janice Dutcher United States 9 2.6k 1.2× 2.4k 1.2× 1.4k 1.2× 1.1k 1.5× 276 1.1× 13 3.6k
Erhan Gökmen Türkiye 12 2.2k 1.1× 2.1k 1.0× 1.3k 1.1× 1.0k 1.4× 264 1.1× 56 3.4k
Debasish Roychowdhury United States 12 2.1k 1.0× 1.5k 0.7× 876 0.8× 1.1k 1.5× 284 1.2× 19 3.1k
Chen Mei China 14 2.2k 1.0× 1.6k 0.8× 1.0k 0.9× 1.2k 1.6× 283 1.2× 62 3.0k
Norbert Hollaender Switzerland 15 2.5k 1.2× 2.4k 1.2× 1.3k 1.1× 1.0k 1.5× 295 1.2× 29 4.0k
Noboru Nakaigawa Japan 30 1.5k 0.7× 1.8k 0.9× 734 0.6× 719 1.0× 475 1.9× 127 3.3k
James R. Vasselli United States 21 1.2k 0.6× 1.6k 0.8× 1.1k 1.0× 1.2k 1.7× 389 1.6× 37 3.7k
Lauren McCann United States 14 2.5k 1.2× 1.9k 1.0× 1.3k 1.1× 1.1k 1.5× 175 0.7× 30 3.1k
Gladys Urbanowitz United States 8 2.2k 1.1× 1.9k 1.0× 996 0.9× 2.0k 2.8× 575 2.3× 12 4.2k

Countries citing papers authored by Zoran Kovačević

Since Specialization
Citations

This map shows the geographic impact of Zoran Kovačević's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoran Kovačević with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoran Kovačević more than expected).

Fields of papers citing papers by Zoran Kovačević

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoran Kovačević. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoran Kovačević. The network helps show where Zoran Kovačević may publish in the future.

Co-authorship network of co-authors of Zoran Kovačević

This figure shows the co-authorship network connecting the top 25 collaborators of Zoran Kovačević. A scholar is included among the top collaborators of Zoran Kovačević based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoran Kovačević. Zoran Kovačević is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kovačević, Zoran, Tatjana Lazarević, Nela Maksimović, et al.. (2022). Galectin 3 (LGALS3) Gene Polymorphisms Are Associated with Biochemical Parameters and Primary Disease in Patients with End-Stage Renal Disease in Serbian Population. Journal of Clinical Medicine. 11(13). 3874–3874. 2 indexed citations
2.
Kovačević, Zoran, et al.. (2022). Quality of Life of Children Engaged in Regular Physical Activities. Iranian Journal of Public Health. 51(7). 1629–1636. 2 indexed citations
3.
Kovačević, Zoran, et al.. (2021). Clinical analysis of peritonitis in peritoneal dialysis patients. SHILAP Revista de lepidopterología. 149(5-6). 282–287. 2 indexed citations
4.
Brosnan, John T., et al.. (2015). Hormonal and Dietary Control of Hepatic Glutamine Catabolism1. Contributions to nephrology. 110. 109–114. 1 indexed citations
5.
Kovačević, Zoran, et al.. (2014). A Toxic Hepatitis Caused the Kombucha Tea – Case Report. Open Access Macedonian Journal of Medical Sciences. 2(1). 128–131. 12 indexed citations
6.
Kovačević, Zoran, et al.. (2013). Conversion from calcineurin inhibitors to sirolimus of recipients with chronic kidney graft disease grade iii for a period 2003-2011. Vojnosanitetski pregled. 70(9). 848–853. 2 indexed citations
7.
Kovačević, Zoran, Branka Mitić, Nada Dimković, et al.. (2010). Treatment of Lupus Nephritis by Mycophenolate Mofetil. Kidney & Blood Pressure Research. 33(4). 297–303. 6 indexed citations
8.
Dimković, Nada, Dragan Jovanović, Zoran Kovačević, et al.. (2009). Mycophenolate Mofetil in High-Risk Patients with Primary Glomerulonephritis: Results of a 1-Year Prospective Study. Nephron Clinical Practice. 111(3). c189–c196. 13 indexed citations
9.
Jovanović, Dragan, et al.. (2009). Anterior pituitary lobe atrophy as late complication of hemorrhagic fever with renal syndrome. Vojnosanitetski pregled. 66(2). 166–168. 2 indexed citations
10.
Ležaić, Višnja, et al.. (2008). Comparison of Kidney Size between Patients with Balkan Endemic Nephropathy and Other Kidney Diseases. Kidney & Blood Pressure Research. 31(5). 307–312. 4 indexed citations
11.
Dimitrijević, J, et al.. (2008). Asymptomatic urinary abnormalities: Histopathological analysis. Pathology - Research and Practice. 205(5). 295–302. 6 indexed citations
12.
Drašković, Biljana, et al.. (2008). Efikasnost terapijskog monitoringa ciklosporina odredjivanjem C2 i PIK0−4 tokom prva 24 meseca posle transplantacije bubrega. Vojnosanitetski pregled. 65(2). 119–127. 2 indexed citations
13.
Hudes, Gary R., Michael A. Carducci, Piotr Tomczak, et al.. (2007). Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma. New England Journal of Medicine. 356(22). 2271–2281. 2817 indexed citations breakdown →
14.
Stankov, Karmen, et al.. (2007). Alpha-tocopheryl succinate (α-TOS) influences cell vitality and enzyme activity in Ehrlich ascites carcinoma cells. Archive of oncology. 15(3-4). 65–68. 1 indexed citations
15.
Jovanović, Dragan, et al.. (2007). Mycophenolate mofetil combined with steroids: New experiences in the treatment of idiopathic retroperitoneal fibrosis. Vojnosanitetski pregled. 64(6). 385–390. 3 indexed citations
16.
17.
18.
Watford, Malcolm, et al.. (1994). Transcriptional Control of Rat Hepatic Glutaminase Expression by Dietary Protein Level and Starvation ,. Journal of Nutrition. 124(4). 493–499. 19 indexed citations
19.
Kovačević, Zoran. (1976). Tetraphenylboron — a potent activator of kidney mitochondrial glutaminase. FEBS Letters. 65(2). 179–182. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David McDermott Breakdown of academic impact, for papers by Janice Dutcher Breakdown of academic impact, for papers by Erhan Gökmen Breakdown of academic impact, for papers by Debasish Roychowdhury Breakdown of academic impact, for papers by Chen Mei Breakdown of academic impact, for papers by Norbert Hollaender Breakdown of academic impact, for papers by Noboru Nakaigawa Breakdown of academic impact, for papers by James R. Vasselli Breakdown of academic impact, for papers by Lauren McCann Breakdown of academic impact, for papers by Gladys Urbanowitz
Rankless by CCL
2026